Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pleural Effusion, Malignant

• Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer
• Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion
• A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC
• Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin
• A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion
• Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
• IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites
• A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
• Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion
• Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.
• Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion
• A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion
• Comparison of the Effectiveness of Povidone-Iodine Alone to Povidone-Iodine-Tetracycline Combination
• A Randomized Study of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLC
• Talc Outpatient Pleurodesis With Indwelling Catheter
• Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
• Management of Malignant Pleural Effusion With Indwelling Pleural Catheter Versus Silver Nitrate Pleurodesis
• A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites
• The Safety and Efficacy of Fibrinolysis in Patients With an Indwelling Pleural Catheter for Multi-loculated Malignant Pleural Effusion.
• A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion
• Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
• Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer
• Rapid Pleurodesis Through an Indwelling Pleural Catheter
• Betadine Pleurodesis Via Tunneled Pleural Catheters
• Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
• Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis
• Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies
• Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
• Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion
• Indwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
• Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion
• Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
• Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast Cancer
• Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
• Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions
• Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
• Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
• Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
• Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion
• Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
• Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
• The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection
• Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population
• Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
• Cediranib as Palliative Treatment in Patients With Symptomatic Malignant Ascites or Pleural Effusion
• Safety and Effectiveness Study for Pleurodesis With Silver Nitrate in Malignant Pleural Effusion
• Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer
• Ibuprofen or Morphine in Treating Pain in Patients Undergoing Pleurodesis for Malignant Pleural Effusion
• FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
• BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)
• AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer
• Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
• Malignant Pleural Effusion With ZD6474
• Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer
• The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer
• Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
• Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
• Surgery and Intrapleural Docetaxel in Treating Patients With Malignant Pleural Effusion
• Non-small Cell Lung Cancer Registry
• Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
• Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
• Talc in Treating Patients With Malignant Pleural Effusion